Abstract
Background
Drug rotation to prevent opioid tolerance is well recognized in chronic pain management. However, ketamine infusion as a counter measure for opioid tolerance is rarely described in mechanically ventilated children developing tolerance from prolonged opioid infusion.
Patients and Methods
We performed a retrospective study in a 14-bed medical-surgical-cardiac pediatric intensive care unit. Thirty-two mechanically ventilated children who had developed tolerance from prolonged intravenous infusion of opioids received a continuous intravenous infusion of ketamine as an opioid substitute for more than 2 days, scheduled in a drug rotation protocol.
Results
Thirty-two children (median age 2.5 years, range 0.1–16.0; weight 11.2 kg [3.8–62.0]) were included. Patients had received continuous intravenous infusion of opioids and benzodiazepines for 16.0 days (4.0–34.0) when drug rotation was started. The median dose of continuous intravenous infusion of ketamine was 4.0 mg·kg−1·h−1 (1.8–6.0) and the median duration was 3.0 days (2.0–6.0). After having restarted opioids, fentanyl doses were significantly lower compared with the time before the drug rotation began (after, 2.9 µg·kg−1·h−1 [0.8–4.9] vs before, 4.15 µg·kg−1·h−1 [1.2–10.0]; p < 0.001). Continuous intravenous infusion of midazolam and clonidine were unchanged during drug rotation. COMFORT-B scoring was significantly lower after having started drug rotation (after, 14.5 [8–19] vs before, 16 [11–22]; p < 0.001).
Conclusion
Drug rotation with ketamine in mechanically ventilated children with opioid tolerance is feasible and seems to reduce the rate of fentanyl infusion.
Similar content being viewed by others
References
Jenkins IA, et al. Current United Kingdom sedation practice in pediatric intensive care. Paediatr Anaesth. 2007;17(7):675–83.
Anand KJ, et al. Summary proceedings from the neonatal pain-control group. Pediatrics. 2006;117(3 Pt 2):S9–22.
Anand KS. Relationships between stress responses and clinical outcome in newborns, infants, and children. Crit Care Med. 1993;21(9 Suppl):S358–9.
Simons SH, Anand KJ. Pain control: opioid dosing, population kinetics and side-effects. Semin Fetal Neonatal Med. 2006;11(4):260–7.
Anand KJ, et al. Tolerance and withdrawal from prolonged opioid use in critically ill children. Pediatrics. 2010;125(5):e1208–25.
Bardo MT, Hughes RA. Single-dose tolerance to morphine-induced analgesic and hypoactive effects in infant rats. Dev Psychobiol. 1981;14(5):415–23.
Tobias JD. Tolerance, withdrawal, and physical dependency after long-term sedation and analgesia of children in the pediatric intensive care unit. Crit Care Med. 2000;28(6):2122–32.
Katz R, Kelly HW. Pharmacokinetics of continuous infusions of fentanyl in critically ill children. Crit Care Med. 1993;21(7):995–1000.
Schulz S, Hollt V. Opioid withdrawal activates MAP kinase in locus coeruleus neurons in morphine-dependent rats in vivo. Eur J Neurosci. 1998;10(3):1196–201.
Avidor-Reiss T, et al. Opiate-induced adenylyl cyclase superactivation is isozyme-specific. J Biol Chem. 1997;272(8):5040–7.
Celerier E, et al. Long-lasting hyperalgesia induced by fentanyl in rats: preventive effect of ketamine. Anesthesiology. 2000;92(2):465–72.
Mauermann E, et al. Does fentanyl lead to opioid-induced hyperalgesia in healthy volunteers? A double-blind, randomized, crossover trial. Anesthesiology. 2016;124(2):453–63.
Kissin I, Bright CA, Bradley EL Jr. The effect of ketamine on opioid-induced acute tolerance: can it explain reduction of opioid consumption with ketamine-opioid analgesic combinations? Anesth Analg. 2000;91(6):1483–8.
Luginbuhl M, et al. Modulation of remifentanil-induced analgesia, hyperalgesia, and tolerance by small-dose ketamine in humans. Anesth Analg. 2003;96(3):726–32.
Playfor SD, Thomas DA, Choonara I. Sedation and neuromuscular blockade in paediatric intensive care: a review of current practice in the UK. Paediatr Anaesth. 2003;13(2):147–51.
Cunliffe M, McArthur L, Dooley F. Managing sedation withdrawal in children who undergo prolonged PICU admission after discharge to the ward. Paediatr Anaesth. 2004;14(4):293–8.
Ista E, et al. Assessment of sedation levels in pediatric intensive care patients can be improved by using the COMFORT “behavior” scale. Pediatr Crit Care Med. 2005;6(1):58–63.
Playfor S, et al. Consensus guidelines on sedation and analgesia in critically ill children. Intensive Care Med. 2006;32(8):1125–36.
Anand KJ, et al. Opioid analgesia in mechanically ventilated children: results from the multicenter measuring opioid tolerance induced by Fentanyl study. Pediatr Crit Care Med. 2013;14(1):27–36.
Neunhoeffer F, et al. Nurse-driven pediatric analgesia and sedation protocol reduces withdrawal symptoms in critically ill medical pediatric patients. Paediatr Anaesth. 2015;25(8):786–94.
Vet NJ, et al. Optimal sedation in pediatric intensive care patients: a systematic review. Intensive Care Med. 2013;39(9):1524–34.
Cohen SP, et al. Ketamine in pain management. Adv Psychosom Med. 2011;30:139–61.
Subramaniam K, Subramaniam B, Steinbrook RA. Ketamine as adjuvant analgesic to opioids: a quantitative and qualitative systematic review. Anesth Analg. 2004;99(2):482–95.
Park GR, et al. Ketamine infusion. Its use as a sedative, inotrope and bronchodilator in a critically ill patient. Anaesthesia. 1987;42(9):980–3.
Jin HS, et al. The efficacy of the COMFORT scale in assessing optimal sedation in critically ill children requiring mechanical ventilation. J Korean Med Sci. 2007;22(4):693–7.
Miller AC, Jamin CT, Elamin EM. Continuous intravenous infusion of ketamine for maintenance sedation. Minerva Anestesiol. 2011;77(8):812–20.
Atangana R, et al. Morphine versus morphine–ketamine association in the management of post operative pain in thoracic surgery. Acta Anaesthesiol Belg. 2007;58(2):125–7.
Bossard AE, et al. Interaction of a combination of morphine and ketamine on the nociceptive flexion reflex in human volunteers. Pain. 2002;98(1–2):47–57.
Lauretti GR, et al. Oral ketamine and transdermal nitroglycerin as analgesic adjuvants to oral morphine therapy for cancer pain management. Anesthesiology. 1999;90(6):1528–33.
Huang C, et al. Ketamine enhances the efficacy to and delays the development of tolerance to electroacupuncture-induced antinociception in rats. Neurosci Lett. 2005;375(2):138–42.
Shimoyama N, et al. Ketamine attenuates and reverses morphine tolerance in rodents. Anesthesiology. 1996;85(6):1357–66.
Ikonomidou C, et al. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science. 1999;283(5398):70–4.
Moryl N, et al. Pitfalls of opioid rotation: substituting another opioid for methadone in patients with cancer pain. Pain. 2002;96(3):325–8.
Drake R, Longworth J, Collins JJ. Opioid rotation in children with cancer. J Palliat Med. 2004;7(3):419–22.
Quigley C. Opioid switching to improve pain relief and drug tolerability. Cochrane Database Syst Rev 2004(3):CD004847.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Ethics
The study protocol was approved by the Ethics Committee of Tuebingen University Hospital (634/2011BO1).
Funding
No funding was received for the conduct of this study.
Conflict of interest
Felix Neunhoeffer, Anja Hanser, Martin Esslinger, Vanja Icheva, Matthias Kumpf, Ines Gerbig, Michael Hofbeck and Jörg Michel declare that they have no conflict of interest that might be relevant to the contents of this manuscript.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Neunhoeffer, F., Hanser, A., Esslinger, M. et al. Ketamine Infusion as a Counter Measure for Opioid Tolerance in Mechanically Ventilated Children: A Pilot Study. Pediatr Drugs 19, 259–265 (2017). https://doi.org/10.1007/s40272-017-0218-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40272-017-0218-4